Clinical Trial

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Name: Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain — clinical trial record (NCT07197645)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SOLACE

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in patients with painful bone metastases.

Protocol Amendment History 1 change

notable Trial sites expanded: 3 -> 6 locations 2026-05-15

Trial Details

NCT Number	NCT07197645
Lead Sponsor	Telix Pharmaceuticals (Innovations) Pty Limited
Conditions	Bone Pain, Metastatic Bone Tumor, Bone Metastases in Subjects With Advanced Cancer
Enrollment	33 participants
Start Date	2025-10-21
Primary Completion	2027-04-26 (estimated)
Study Completion	2027-07-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-14